REGNON
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion.
Name REGNON
Rank No.3690
Market Cap $12.89K
Fully Diluted Market Cap $12.89K
Market Share %
Trading Vol/Market Cap (24H) 1,790,525.06%
Circulation Supply 14.35
Max Supply 0
Total Supply 14.3542605
Circulation Rate %
Issue Date --
The price at which the asset was first issued --
All-Time High 1000.4620892596903, 2026-11-04
Lowest Price 595.2849688688211, 2026-06-02
Public Blockchain REGNON
Introduction Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion.
Sector
- common.mc-trade-zone-xStocks
Social Media
Fund Flow Analysis
|
Buy(REGNON) |
Sell(REGNON) |
Net Inflow |
| Big |
0.000 |
0.000 |
0.000 |
| Medium |
0.000 |
0.000 |
0.000 |
| Small |
247.633 |
249.478 |
-1.845 |
| Total |
247.633 |
249.478 |
-1.845 |
Disclaimer: Data provided by cmc and should not be considered as investment advice.